Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
By M. Resnick, T. Koyama, K. Fan, P. Albertsen, M. Goodman, A. Hamilton, R. Hoffman, A. Potosky, J. Stanford, A. Stroup and 2 more. New England Journal of Medicine, 2013
925 citations recorded by the source corpus.
Background The purpose of this analysis was to compare long-term urinary, bowel, and sexual function after radical prostatectomy or external-beam radiation therapy. Methods The Prostate Cancer Outcomes Study (PCOS) enrolled 3533 men in whom prostate cancer had been diagnosed in 1994 or 1995. The current cohort comprised 1655 men in whom localized prostate cancer had been diagnosed between the ages of 55 and 74 years and who had undergone either surgery (1164 men) or radiotherapy (491 men). Functional status was assessed at baseline and at 2, 5, and 15 years after diagnosis. We used multivariable propensity scoring to compare functional outcomes according to treatment. Results Patients undergoing prostatectomy were more likely to have urinary incontinence than were those undergoing radiotherapy at 2 years (odds ratio, 6.22; 95% confidence interval [CI], 1.92 to 20.29) and 5 years (odds ratio, 5.10; 95% CI, 2.29 to 11.36). However, no significant between-group difference in the odds of urinary incontinence was noted at 15 years. Similarly, although patients undergoing prostatectomy were more likely to have erectile dysfunction at 2 years (odds ratio, 3.46; 95% CI, 1.93 to 6.17) and 5 years (odds ratio, 1.96; 95% CI, 1.05 to 3.63), no significant between-group difference was noted at 15 years. Patients undergoing prostatectomy were less likely to have bowel urgency at 2 years (odds ratio, 0.39; 95% CI, 0.22 to 0.68) and 5 years (odds ratio, 0.47; 95% CI, 0.26 to 0.84), again with no significant between-group difference in the odds of bowel urgency at 15 years. Conclusions At 15 years, no significant relative differences in disease-specific functional outcomes were observed among men undergoing prostatectomy or radiotherapy. Nonetheless, men treated for localized prostate cancer commonly had declines in all functional domains during 15 years of follow-up. (Funded by the National Cancer Institute.)
Subfields: Pulmonary and Respiratory Medicine, Urology
View Paper: https://www.semanticscholar.org/paper/026ea0ca20695a88e61be7f0460199881b11f8d4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Cancer treatment and survivorship statistics, 2014 (2014, neutral): “incontinence, erectile dysfunction, and bowel complications.(80) Patients receiving hormonal treatment may experience loss of libido; erectile dysfunction; menopausallike symptoms including hot flashes, night sweats, and irritability; and gynecomastia.”
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score (2015, neutral): “Analyzing some of the highest impact recent articles on PCa reveals considerable diversity of Gleason score groupings: 2–4, 5–7, 8–10 (Prostate Cancer Outcomes Study) [7]; 2–6, 7, 8–10 (Scandinavian Prostate Cancer Group Study); and 2–6, 7–10 (Prostate Cancer Prevention Trial and Prostate Cancer Int”
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2020, result): “The findings regarding RP and RT are supported by other observational studies [177,178].”